663 related articles for article (PubMed ID: 18284179)
1. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S; Warner N
Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus mutations associated with antiviral therapy.
Bartholomeusz A; Locarnini S
J Med Virol; 2006; 78 Suppl 1():S52-5. PubMed ID: 16622878
[TBL] [Abstract][Full Text] [Related]
3. Molecular virology and the development of resistant mutants: implications for therapy.
Locarnini S
Semin Liver Dis; 2005; 25 Suppl 1():9-19. PubMed ID: 16103977
[TBL] [Abstract][Full Text] [Related]
4. Molecular genesis of drug-resistant and vaccine-escape HBV mutants.
Locarnini SA; Yuen L
Antivir Ther; 2010; 15(3 Pt B):451-61. PubMed ID: 20516565
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of HBV infection.
Locarnini S; Zoulim F
Antivir Ther; 2010; 15 Suppl 3():3-14. PubMed ID: 21041899
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatitis B patients with antiviral resistance.
Fung SK; Lok AS
Antivir Ther; 2004 Dec; 9(6):1013-26. PubMed ID: 15651760
[TBL] [Abstract][Full Text] [Related]
7. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance in antiviral therapy.
Locarnini S; Bowden S
Clin Liver Dis; 2010 Aug; 14(3):439-59. PubMed ID: 20638024
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus genetic diversity.
Echevarría JM; Avellón A
J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
11. Special considerations and treatment of patients with HBV-HIV coinfection.
Dieterich DT
Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
[TBL] [Abstract][Full Text] [Related]
12. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
13. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
14. Potential threat of drug-resistant and vaccine-escape HBV mutants to public health.
Teo CG; Locarnini SA
Antivir Ther; 2010; 15(3 Pt B):445-9. PubMed ID: 20516564
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
Fournier C; Zoulim F
Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
[TBL] [Abstract][Full Text] [Related]
16. Management of antiviral resistance in patients with chronic hepatitis B.
Locarnini S; Hatzakis A; Heathcote J; Keeffe EB; Liang TJ; Mutimer D; Pawlotsky JM; Zoulim F
Antivir Ther; 2004 Oct; 9(5):679-93. PubMed ID: 15535405
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
Revill PA; Littlejohn M; Ayres A; Yuen L; Colledge D; Bartholomeusz A; Sasaduesz J; Lewin SR; Dore GJ; Matthews GV; Thio CL; Locarnini SA
AIDS; 2007 Aug; 21(13):1701-10. PubMed ID: 17690567
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus escape mutants induced by antiviral therapy.
Sheldon J; Soriano V
J Antimicrob Chemother; 2008 Apr; 61(4):766-8. PubMed ID: 18218641
[TBL] [Abstract][Full Text] [Related]
19. Antiviral drug resistance: clinical consequences and molecular aspects.
Bartholomeusz A; Locarnini SA
Semin Liver Dis; 2006 May; 26(2):162-70. PubMed ID: 16673294
[TBL] [Abstract][Full Text] [Related]
20. Short communication: transmission of hepatitis B viruses with lamivudine resistance mutations in newly diagnosed HIV individuals.
Treviño A; Soriano V; Madejon A; Rodriguez C; Barros C; Botecchia M; Tuma P; Del Romero J; de Mendoza C
AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1273-6. PubMed ID: 20001517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
